The knockout mice demonstrated lower NAFLD activity score, less severe hepatic inflammation, fat accumulation and fibrosis, lower plasma ALT and AST levels, and reduced liver weight to body weight ratio [111]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.